, Volume 42, Supplement 4, pp 30–32 | Cite as

Efficacy and Tolerability of Cefixime in Otitis Media

A Multicentre Study in over 25 000 Children
  • D. H. Wu


A large scale multicentre clinical study was undertaken to assess the efficacy and tolerability of cefixime in the treatment of acute otitis media in children. A total of 25 863 evaluable children with acute otitis media received cefixime 8 mg/kg once daily for at least 10 days.

At the end of treatment, 86% of patients were considered to be either cured or improved. These results are consistent with those achieved with cefixime in controlled clinical trials. Adverse effects were reported in 11.5% of patients, but were judged to be related to cefixime therapy in only 9.4% of patients.

The results of this study demonstrate that cefixime is an effective and well tolerated treatment for acute otitis media in children.


Otitis Medium Acute Otitis Medium Cefixime Amox Large Scale Clinical Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Hussar DA. Importance of patient compliance in effective antimicrobial therapy. Pediatric Infectious Disease Journal 6: 971–975, 1987PubMedCrossRefGoogle Scholar
  2. Kovatch AL, Wald ER, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. Journal of Pediatrics 102: 261–264, 1983PubMedCrossRefGoogle Scholar
  3. McLeod DT, Ahmad F, Calder MA. Infection and Branhamella catarrhalis. Biomedicine and Pharmacotherapy 39: 170–173, 1985Google Scholar
  4. Schwartz RH, Rodriguez WJ. Amoxicillin as the drug of choice for acute otitis media: isn’t it time for its reassessment in some areas of the country? Pediatric Infectious Disease Journal 8: 806, 1989PubMedGoogle Scholar
  5. Van Hare GF, Shurin PA, Marchant CD, et al. Acute otitis media caused by Branhamella catarrhalis. Biology and therapy. Reviews of Infectious Diseases 9: 16–27, 1987PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1991

Authors and Affiliations

  • D. H. Wu
    • 1
  1. 1.Lederle LaboratoriesPearl RiverUSA

Personalised recommendations